# PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28

> **NCT00526916** · PHASE1 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 18 (actual)

## Conditions studied

- Neurocysticercosis
- Healthy

## Interventions

- **DRUG:** [C-11]PBR28

## Key facts

- **NCT ID:** NCT00526916
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09-04
- **Primary completion:** —
- **Final completion:** 2014-09-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00526916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00526916, "PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00526916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*